Drawing for MORE THAN A 100 WAYS TO SAY I LOVE YOU

USPTO serial 77609086

MORE THAN A 100 WAYS TO SAY I LOVE YOU

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
MILTON, PRISCILLA
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with MORE THAN A 100 WAYS TO SAY I LOVE YOU?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Ira E. Silfin

Ira E. Silfin Mandelbaum Silfin Economou LLP222 Bloomingdale RoadSuite 120White Plains, NY 10605

Goods and services

ClassDescriptionStatusFirst use
014JewelryACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (ARAA): This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.

DateCodeEventWhat it means
Feb 7, 2019ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 7, 2019REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Oct 31, 2018ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 31, 2018REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Dec 7, 2009MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Dec 7, 2009ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
May 5, 2009NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Feb 10, 2009PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 21, 2009NPUBNOTICE OF PUBLICATION—
Jan 2, 2009PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Dec 30, 2008CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 30, 2008TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 30, 2008ALIEASSIGNED TO LIE—
Dec 30, 2008ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Dec 15, 2008CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 15, 2008PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Dec 12, 2008CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 11, 2008DOCKASSIGNED TO EXAMINER—
Nov 10, 2008NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance